Moffitt Cancer Center Showcases Startups at 9th Annual Business of Biotech Conference

March 24, 2015

TAMPA, Fla. – Biotech startups working to make advances in cancer treatment and patient care will be spotlighted at Moffitt Cancer Center’s ninth annual Business of Biotech Conference. The event, which brings together biomedical companies, startups, research organizations, entrepreneurs and investors, offers networking, collaboration and partnership opportunities. This year’s conference is April 17, 7:45 a.m. – 4 p.m., in Moffitt’s Vincent A. Stabile Research Building.

“Business of Biotech has quickly become one of the premier biotechnology conferences in Florida. This conference gives Moffitt the opportunity to spotlight the cutting-edge technologies of its researchers and connect them with investors and collaborators in their field,” said Jarett Rieger, conference chairman and director of Moffitt’s Office of Technology Management and Commercialization. “Moffitt is known for its translational research; and partnerships built at this conference can help bring our discoveries from the lab to the marketplace more quickly, benefiting patients worldwide.”

This year’s keynote address will feature Henri Termeer, former CEO, chairman and president of Genzyme. Termeer built Genzyme, a pioneer in developing treatments for rare diseases, to the world’s third largest biotech company before selling it in 2010. Following an interview-style format, Sam Donaldson, former ABC News correspondent and Moffitt Board of Advisors member, will lead Termeer through a series of questions about his entrepreneurial ventures in the biotech field and how he sees the industry growing in the Tampa Bay region.

“This is a huge ‘get’ for our conference. Henri Termeer is world-renowned for his contributions to the healthcare and the biotech industries. This unique interview-style keynote address will provide attendees with valuable advice they can use to grow their companies,” said Rieger.  

In addition to the keynote address, the conference will include breakout sessions on fundraising trends, building strategic pharma-academia partnerships and healthcare startups for the tech savvy.

There will also be a “fast pitch” session for startups. Similar to the format of ABC’s “Shark Tank,” entrepreneurs will be given 90 seconds to get a group of panelists excited about their companies. This opportunity allows companies to receive immediate feedback about their pitches. Startups participating in this session include:

  •          HealthMyne, Inc., a healthcare IT company that brings evidence-based imaging analysis and actionable insights to the point of care;
  •          Medical Device Investments, Inc., a Tampa company that licenses and commercializes medical devices;
  •          Xcelerated Learning Dynamics, Inc., a startup that develops innovative educational programs designed to improve patient satisfaction scores in hospitals and outpatient office environments.

Business of Biotech is free and open to the public, but seating is limited and reservations are required. To register, visit http://bit.ly/MoffittBOB2015.  

About Moffitt Cancer Center
Located in Tampa, Moffitt is one of only 41 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s excellence in research, its contributions to clinical trials, prevention and cancer control. Moffitt is the top-ranked cancer hospital in the Southeast and has been listed in U.S. News & World Report as one of the “Best Hospitals” for cancer care since 1999. With more than 4,500 employees, Moffitt has an economic impact in Florida of nearly $1.6 billion. For more information, visit MOFFITT.org, and follow the Moffitt momentum on FacebookTwitter and YouTube.

###